Protocatechualdehyde

This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Generic Name
Protocatechualdehyde
DrugBank Accession Number
DB11268
Background

Also known as protocatechuic aldehyde, protocatechualdehyde is a naturally-occuring phenolic aldehyde that is found in barley, green cavendish bananas, grapevine leaves and root of the herb S. miltiorrhiza 1. Protocatechualdehyde possesses antiproliferative and pro-apoptotic properties against human breast cancer cells and colorectal cancer cells by reducing the expression of pro-oncogenes β-catenin and cyclin D1.

Type
Small Molecule
Groups
Experimental
Structure
Thumb
Weight
Average: 138.1207
Monoisotopic: 138.031694058
Chemical Formula
C7H6O3
Synonyms
  • 3,4-dihydroxybenzaldehyde
  • Protocatechuic aldehyde
  • Rancinamycin IV
External IDs
  • NSC-22961

Pharmacology

Indication

Not Available

Pharmacology
Accelerate your drug discovery research with the industry’s only fully connected ADMET dataset, ideal for:
Machine Learning
Data Science
Drug Discovery
Accelerate your drug discovery research with our fully connected ADMET dataset
Learn more
Contraindications & Blackbox Warnings
Contraindications
Contraindications & Blackbox Warnings
With our commercial data, access important information on dangerous risks, contraindications, and adverse effects.
Learn more
Our Blackbox Warnings cover Risks, Contraindications, and Adverse Effects
Learn more
Pharmacodynamics

Not Available

Mechanism of action
Not Available
Absorption

Not Available

Volume of distribution

Not Available

Protein binding

Not Available

Metabolism
Not Available
Route of elimination

Not Available

Half-life

Not Available

Clearance

Not Available

Adverse Effects
Medicalerrors
Reduce medical errors
and improve treatment outcomes with our comprehensive & structured data on drug adverse effects.
Learn more
Reduce medical errors & improve treatment outcomes with our adverse effects data
Learn more
Toxicity

Not Available

Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
DrugInteraction
AbciximabThe risk or severity of bleeding can be increased when Abciximab is combined with Protocatechualdehyde.
AcenocoumarolThe risk or severity of bleeding can be increased when Acenocoumarol is combined with Protocatechualdehyde.
AlteplaseThe risk or severity of bleeding can be increased when Protocatechualdehyde is combined with Alteplase.
AncrodThe risk or severity of bleeding can be increased when Ancrod is combined with Protocatechualdehyde.
AnistreplaseThe risk or severity of bleeding can be increased when Protocatechualdehyde is combined with Anistreplase.
Antithrombin AlfaThe risk or severity of bleeding can be increased when Protocatechualdehyde is combined with Antithrombin Alfa.
Antithrombin III humanThe risk or severity of bleeding can be increased when Protocatechualdehyde is combined with Antithrombin III human.
ApixabanThe risk or severity of adverse effects can be increased when Protocatechualdehyde is combined with Apixaban.
ArdeparinThe risk or severity of bleeding can be increased when Ardeparin is combined with Protocatechualdehyde.
ArgatrobanThe risk or severity of bleeding can be increased when Argatroban is combined with Protocatechualdehyde.
Interactions
Improve patient outcomes
Build effective decision support tools with the industry’s most comprehensive drug-drug interaction checker.
Learn more
Food Interactions
No interactions found.

Products

Products
Comprehensive & structured drug product info
From application numbers to product codes, connect different identifiers through our commercial datasets.
Learn more
Easily connect various identifiers back to our datasets
Learn more
Over the Counter Products
NameDosageStrengthRouteLabellerMarketing StartMarketing EndRegionImage
O Hui White Extreme CellightCream0.032 mL/100mLTopicalLg Household & Health Care Ltd.2011-03-16Not applicableUS flag
O Hui White Extreme CellightEmulsion0.0315 mL/100mLTopicalLg Household & Health Care Ltd.2011-03-07Not applicableUS flag
Unapproved/Other Products
NameIngredientsDosageRouteLabellerMarketing StartMarketing EndRegionImage
O Hui White Extreme CellightProtocatechualdehyde (0.032 mL/100mL)CreamTopicalLg Household & Health Care Ltd.2011-03-16Not applicableUS flag
O Hui White Extreme CellightProtocatechualdehyde (0.0315 mL/100mL)EmulsionTopicalLg Household & Health Care Ltd.2011-03-07Not applicableUS flag

Categories

Drug Categories
Chemical TaxonomyProvided by Classyfire
Description
This compound belongs to the class of organic compounds known as hydroxybenzaldehydes. These are organic aromatic compounds containing a benzene ring carrying an aldehyde group and a hydroxyl group.
Kingdom
Organic compounds
Super Class
Organic oxygen compounds
Class
Organooxygen compounds
Sub Class
Carbonyl compounds
Direct Parent
Hydroxybenzaldehydes
Alternative Parents
Catechols / Benzoyl derivatives / 1-hydroxy-4-unsubstituted benzenoids / 1-hydroxy-2-unsubstituted benzenoids / Organic oxides / Hydrocarbon derivatives
Substituents
1-hydroxy-2-unsubstituted benzenoid / 1-hydroxy-4-unsubstituted benzenoid / Aromatic homomonocyclic compound / Benzenoid / Benzoyl / Catechol / Hydrocarbon derivative / Hydroxybenzaldehyde / Monocyclic benzene moiety / Organic oxide
Molecular Framework
Aromatic homomonocyclic compounds
External Descriptors
dihydroxybenzaldehyde (CHEBI:50205) / an aryl aldehyde (CPD-7616)
Affected organisms
Not Available

Chemical Identifiers

UNII
4PVP2HCH4T
CAS number
139-85-5
InChI Key
IBGBGRVKPALMCQ-UHFFFAOYSA-N
InChI
InChI=1S/C7H6O3/c8-4-5-1-2-6(9)7(10)3-5/h1-4,9-10H
IUPAC Name
3,4-dihydroxybenzaldehyde
SMILES
[H]C(=O)C1=CC(O)=C(O)C=C1

References

General References
  1. Jeong JB, Lee SH: Protocatechualdehyde possesses anti-cancer activity through downregulating cyclin D1 and HDAC2 in human colorectal cancer cells. Biochem Biophys Res Commun. 2013 Jan 4;430(1):381-6. doi: 10.1016/j.bbrc.2012.11.018. Epub 2012 Nov 14. [Article]
  2. Choi J, Jiang X, Jeong JB, Lee SH: Anticancer activity of protocatechualdehyde in human breast cancer cells. J Med Food. 2014 Aug;17(8):842-8. doi: 10.1089/jmf.2013.0159. Epub 2014 Apr 8. [Article]
Human Metabolome Database
HMDB0059965
KEGG Compound
C16700
PubChem Compound
8768
PubChem Substance
347827959
ChemSpider
8438
BindingDB
50192743
RxNav
1362689
ChEBI
50205
ChEMBL
CHEMBL222021
ZINC
ZINC000000013245
PDBe Ligand
H6N
Wikipedia
Protocatechuic_aldehyde
PDB Entries
6i73

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
FormRouteStrength
CreamTopical0.032 mL/100mL
EmulsionTopical0.0315 mL/100mL
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available
Predicted Properties
PropertyValueSource
Water Solubility14.3 mg/mLALOGPS
logP0.89ALOGPS
logP1.08ChemAxon
logS-0.99ALOGPS
pKa (Strongest Acidic)7.46ChemAxon
pKa (Strongest Basic)-6.3ChemAxon
Physiological Charge0ChemAxon
Hydrogen Acceptor Count3ChemAxon
Hydrogen Donor Count2ChemAxon
Polar Surface Area57.53 Å2ChemAxon
Rotatable Bond Count1ChemAxon
Refractivity36.6 m3·mol-1ChemAxon
Polarizability12.87 Å3ChemAxon
Number of Rings1ChemAxon
Bioavailability1ChemAxon
Rule of FiveYesChemAxon
Ghose FilterNoChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleNoChemAxon
Predicted ADMET Features
Not Available

Spectra

Mass Spec (NIST)
Not Available
Spectra
SpectrumSpectrum TypeSplash Key
Predicted GC-MS Spectrum - GC-MSPredicted GC-MSNot Available
Predicted MS/MS Spectrum - 10V, Positive (Annotated)Predicted LC-MS/MSsplash10-000i-0900000000-db13978cfcbc33c6da32
Predicted MS/MS Spectrum - 20V, Positive (Annotated)Predicted LC-MS/MSsplash10-000i-1900000000-ed3a0258f14e4361b25c
Predicted MS/MS Spectrum - 40V, Positive (Annotated)Predicted LC-MS/MSsplash10-0pb9-9200000000-cdb54c91531419396213
Predicted MS/MS Spectrum - 10V, Positive (Annotated)Predicted LC-MS/MSsplash10-000i-0900000000-db13978cfcbc33c6da32
Predicted MS/MS Spectrum - 20V, Positive (Annotated)Predicted LC-MS/MSsplash10-000i-1900000000-ed3a0258f14e4361b25c
Predicted MS/MS Spectrum - 40V, Positive (Annotated)Predicted LC-MS/MSsplash10-0pb9-9200000000-cdb54c91531419396213
Predicted MS/MS Spectrum - 10V, Negative (Annotated)Predicted LC-MS/MSsplash10-000i-0900000000-882b8375384be94a3491
Predicted MS/MS Spectrum - 20V, Negative (Annotated)Predicted LC-MS/MSsplash10-000i-1900000000-25b2a170eaf9dd74c4a0
Predicted MS/MS Spectrum - 40V, Negative (Annotated)Predicted LC-MS/MSsplash10-0kw4-9300000000-e349b638bc98dcdf0ade
Predicted MS/MS Spectrum - 10V, Negative (Annotated)Predicted LC-MS/MSsplash10-000i-0900000000-882b8375384be94a3491
Predicted MS/MS Spectrum - 20V, Negative (Annotated)Predicted LC-MS/MSsplash10-000i-1900000000-25b2a170eaf9dd74c4a0
Predicted MS/MS Spectrum - 40V, Negative (Annotated)Predicted LC-MS/MSsplash10-0kw4-9300000000-e349b638bc98dcdf0ade
MS/MS Spectrum - ESI-TOF 10V, NegativeLC-MS/MSNot Available
MS/MS Spectrum - ESI-TOF 20V, NegativeLC-MS/MSNot Available
MS/MS Spectrum - ESI-TOF , NegativeLC-MS/MSNot Available
MS/MS Spectrum - ESI-TOF 10V, NegativeLC-MS/MSNot Available
MS/MS Spectrum - ESI-TOF 10V, NegativeLC-MS/MSNot Available
MS/MS Spectrum - ESI-TOF 20V, NegativeLC-MS/MSNot Available
MS/MS Spectrum - ESI-TOF , NegativeLC-MS/MSNot Available
MS/MS Spectrum - ESI-TOF 10V, NegativeLC-MS/MSNot Available
LC-MS/MS Spectrum - LC-ESI-TOF , negativeLC-MS/MSsplash10-000i-0900000000-aa91c9c469ec39450435
LC-MS/MS Spectrum - LC-ESI-TOF , negativeLC-MS/MSsplash10-000i-0900000000-25b5b2bc87af9df04e91

Drug created on December 03, 2015 16:51 / Updated on July 11, 2020 03:43